ERCC1 and XRCC1 single nucleotide polymorphisms can guide treatment decision in patients with metastatic non-small cell lung cancer

ERCC1 and XRCC1 single nucleotide polymorphisms can guide treatment decision in patients with metastatic non-small cell lung cancer

Results from studies in several cancers on single nucleotide polymorphisms (SNPs) suggest that DNA repair capacity may have prognostic implication for disease recurrence, survival, and responses to treatment. This study aimed to evaluate the potential prognostic value of SNPs as biomarkers in patien...

Full description

Bibliographic Details
Main Authors: Mustafa Karaagac, Mehmet Artac, Caglayan Geredeli, Melek Karakurt Eryilmaz, Mahmut Selman Yildirim, Tuba Akkuloglu, Ali Inal, Abdurrahman Isikdogan, Hakan Bozcuk, Ahmet Demirkazik
Format: Article
Language:English
Published: Society of Turaz Bilim 2020-03-01
Series:Medicine Science
Subjects:
biomarker
lung cancer
platinum
single nucleotide polymorphism
survival
Online Access:http://www.ejmanager.com/fulltextpdf.php?mno=67923

Internet

http://www.ejmanager.com/fulltextpdf.php?mno=67923

Similar Items